“…In line with present observation Selvabai et al (2017) [20] , Sharma et al (2017) [28] , Li et al (2017) [27] , Ahmad et al (2015) [19] , Al-Zaidi and Al-Sulami (2013) [15] and Kumar et al, (2011) [33] reported fairly similar rate of sesnistivity towards clindamycin. Whereas higher rate of resistance towards clindamycin was reported by Krishnan et al (2019) [21] , Sohail and Latif (2018) [34] and Goyal et al (2013) [24] . Clindamycin, a lincosamide drug could be used to treat MRSA infection because of its good efficacy and pharmacokinetic properties.…”